Incretin Commentary

CE / CME

Addressing the Buzz Around Incretin-Based Therapies With Patients

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: February 21, 2024

Expiration: February 20, 2025

Jennifer B Green
Jennifer B Green, MD
Carol Hatch Wysham
Carol Hatch Wysham, MD

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A patient living with obesity has been taking an incretin-based therapy for weight management for the past 12 months and has achieved their desired weight loss. They ask you if they can stop the medication.

How do you respond?